Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 6 Apr 2004, 17:07 anctioning of the Scheme of Arrangement by the Cou
Ahealth / Bidco - Sanctioning of the Scheme of Arrangement by the Court         
  Business Venture Investments  Afrox Healthcare Limited                          
  No. 790 (Proprietary)         (Incorporated in the                              
  Limited                       Republic of South Africa)                         
  (Incorporated in the          (Registration number:                             
  Republic of South Africa)     1985/001313/06)                                   
  (Registration number:         Share code: AHH                                   
  2003/002733/07)               ISIN: ZAE000022059                                
  ("Bidco")                     ("Ahealth")                                       
  sanctioning of the scheme of arrangement by the court                           
  Further to the announcement published on the Securities Exchange News Service of
  the JSE Securities Exchange South Africa (the "JSE") on Friday, 2 April 2004,   
  shareholders of Ahealth are advised that the scheme of arrangement proposed by  
  Bidco between Ahealth and its shareholders (the "scheme") was sanctioned by the 
  High Court of South Africa (Witwatersrand Local Division) (the "Court") on      
  Tuesday, 6 April 2004.                                                          
  The implementation of the scheme is still subject to the fulfilment of the      
  following conditions precedent:                                                 
  a certified copy of the Order of Court sanctioning the scheme being duly        
  registered by the Registrar of Companies in terms of the Companies Act; and     
  all and any approvals required from the Competition Commission or Tribunal in   
  terms of the Competition Act, 89 of 1998, for the implementation of the         
  transaction being duly obtained.                                                
  As the implementation of the scheme is still subject to the fulfilment of the   
  aforementioned conditions precedent, the estimated last day to trade on the JSE 
  for Ahealth shareholders to be eligible to receive the scheme consideration has 
  been postponed from Wednesday, 7 April 2004 to a date to be advised. As a result
  thereof, the remaining estimated salient dates have also been postponed to dates
  to be advised. A further announcement incorporating the revised salient dates   
  and advising on the fulfilment of the remaining conditions precedent will be    
  made in due course.                                                             
  Johannesburg                                                                    
  6 April 2004                                                                    
  Financial adviser to Bidco    Independent adviser and                           
  Rothschild                    transaction sponsor to                            
  Ahealth                                           
                                Deutsche Securities                               
  Legal adviser to Bidco        Sponsor to Ahealth                                
  Hofmeyr Herbstein & Gihwala   Nedbank Capital                                   
  Inc                                                                             
                                Competition law advisers to                       
                                Ahealth                                           
                                Edward Nathan & Friedland                         
  Date: 06/04/2004 04:55:58 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: